Scollr summary
What this paper is about
TA1 combines favorable BBB permeability with multi-target anti-apoptotic, antioxidant, and anti-inflammatory effects, supporting its further investigation as a candidate for ischemic stroke treatment.
Full abstract
Read the full abstract
Introduction Ischemic stroke involves interconnected pathological processes, including calcium overload, oxidative stress, apoptosis, and inflammation. This complexity challenges therapies directed at a single target, while limited blood–brain barrier (BBB) permeability can restrict drug delivery to the brain. This study aimed to develop hybrid compounds with favorable BBB permeability and multi-target neuroprotective activity. Methods Four adamantane–nitrone hybrids (TA1–TA4) were synthesized and screened for cytotoxicity and neuroprotective activity, leading to the selection of TA1. TA1 was then evaluated for its effects on calcium overload, oxidative stress, mitochondrial function, and BBB permeability in vitro, and for therapeutic efficacy and related signaling pathways in MCAO mice. Single-dose safety was assessed separately. Results TA1 showed the highest neuroprotective activity and lowest cytotoxicity among the four hybrids. It reduced calcium overload, scavenged ROS and ONOO − , and stabilized mitochondrial membrane potential. TA1 exhibited favorable BBB permeability (P app = 6.73 × 10 −6 cm/s) and ameliorated ischemia-induced barrier disruption. In MCAO mice, intravenous TA1 reduced cerebral infarct volume from 32.97% to 14.33%, outperforming the positive control TBN. It also alleviated brain edema and improved neurobehavioral outcomes. TA1 modulated the Bax/Bcl-2/caspase-3, Nrf2/HO-1, and NF-κB pathways. No overt abnormalities were observed in the measured hematological, biochemical, or histopathological indices 48 h after a single intravenous dose of 136 μmol/kg. Discussion TA1 combines favorable BBB permeability with multi-target anti-apoptotic, antioxidant, and anti-inflammatory effects, supporting its further investigation as a candidate for ischemic stroke treatment.
Direct answer
What can I do from this paper page?
Use this page to scan "Novel adamantane-nitrone hybrids: design, synthesis, and their multi-target neuroprotective effects against ischemic stroke" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Neuroprotection in Cerebral Ischemia research, save the paper, or map adjacent work.
Research areas
Follow related topics
Citation
BibTeX
@article{Lu2026Novel,
title = {Novel adamantane-nitrone hybrids: design, synthesis, and their multi-target neuroprotective effects against ischemic stroke},
author = {Hao Lu and Jiaxin Zheng and Ningning Luo and Chi Zhang and Xiao Liu and Xiaotong Wang and Yun Liu and Yong Ling and Xing Su},
journal = {Frontiers in Pharmacology},
year = {2026},
doi = {10.3389/fphar.2026.1974944},
url = {https://doi.org/10.3389/fphar.2026.1974944}
}
FAQ
Using this paper in a discovery workflow
How do I find related work for this paper?
Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.
How can I keep up with new Neuroprotection in Cerebral Ischemia research papers?
Follow Neuroprotection in Cerebral Ischemia research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.
Can I cite this paper from this page?
This page includes a static BibTeX block for Novel adamantane-nitrone hybrids: design, synthesis, and their multi-target neuroprotective effects against ischemic stroke. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.
Follow this research in Scollr
Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.
Get the app